Press Releases

Expanded menu gives researchers broadest coverage of the proteome for increased discovery of biomarkers and drug targets BOULDER, Colo., Nov. 01, 2023 (GLOBE NEWSWIRE) -- SomaLogic Inc., (Nasdaq:SLGC), a leader in data-driven proteomics technology, today announced the launch of its high-plex
Nov 01, 2023
Novo Nordisk will extend its use of SomaLogic’s innovative proteomics technologies for research in cardiometabolic and other diseases BOULDER, Colo., Sept. 05, 2023 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in proteomics technology, announced today that it is extending its collaborative
Sep 05, 2023
Revenue of $20.5 million, an increase of 45% year-over-year Cash and investments of approximately $474 million, a strong capital position to fund current and future business initiatives Reiterating full year 2023 revenue guidance and operating expense target Management to host conference call today
Aug 14, 2023
Displaying 1 - 10 of 24